Condition: Cirrhosis, Liver · Portal Hypertension · Advanced Chronic Liver Disease · Sponsor: Shengjing Hospital
How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate the ability of three demensional-magnetic resonance elastography (3D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis or advanced chronic liver disease.
This description comes directly from the study's public registry record.
Yifei Huang, M.D. · +86 158 0000 4518 · huangyf1995@foxmail.com
Yu Shi, Prof. · +86 189 4025 9980 · 18940259980@163.com
Always discuss trial participation with your own doctor first.
| Shengjing Hospital | Shenyang, Liaoning, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05475015